Session Topics: Medicinal Chemistry, Drug Discovery Innovation, Structure-based Drug Design, Screening, Structural Biology, Toxicology, Systems Biology, Critical Path Advances in Drug Development, Innovation & Knowledge Management in R&D and Clinical Research, Decision Support & Analytics, Drug Safety, Metabolomics, Biomarkers

eCheminfo Conference Sessions & Chairs:
Virtual Screening, chaired by Christopher Austin (NIH)
Structure-based Drug Design, chaired by Jose Duca (Schering-Plough)
Fragment-based Drug Discovery, chaired by Maria Kontoyianni (Crystax Pharmaceuticals)
Structural Biology, chaired by Max Cummings (Johnson & Johnson PR&D)
Predictive ADME/Toxicology, chaired by Tony Hopfinger (University of New Mexico College of Pharmacy)

Confirmed Invited Speakers for eCheminfo Program:
Stephen Burley (SGX Pharmaceuticals), Georgia McGaughey (Merck), Charles Lesburg (Schering-Plough), Rick Beger (FDA), Marc Nicklaus (NIH), Woody Sherman (Schrodinger), Daniel Cheney (Bristol Myers Squibb), Paul Labute (Chemical Computing Group), Ajay Jain (UCSF), Alan Cheng (Amgen), Tony Hopfinger (University of New Mexico), Anthony Klon (Pharmacopeia Drug Discovery), Artem Cherkasov (University of British Columbia), Dennis Pelletier (Pfizer), Chaohong Sun (Abbott), Xavier Barril (University of Barcelona), Jose Duca (Schering-Plough), Terry Stouch (Lexicon Pharmaceuticals), Natasja Brooijmans (Wyeth), Gerard Kleywegt (University of Uppsala), Vladimir Poroikov (Russian Academy of Sciences), Christoph Helma (in silico toxicology), Ann Richard (EPA), Judy Madden (Liverpool John Moores University), Julian Tirado-Rives (Yale), Heather Carlson (University of Michigan), Joseph Tomaszewski (NCI), Joseph Contrera (FDA), Christopher Austin (NIH), Jerome Hert (UCSF), Renate Sekul (Graffinity)

Format: Seminars, Roundtables, Presentations, Panel Q&As, Discussions, Break-out Workshops, Web-supported. Evening Poster sessions, networking, social activities.